Deals & Cases

01/29/2020

On January 29, 2020, Addex Therapeutics Ltd (Addex) (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced the listing of American Depositary Shares (ADSs) representing its ordinary shares on the Nasdaq Stock Market. The ADSs will be listed for trading on Nasdaq under the symbol "ADXN" on January 29, 2020.


Homburger advised Addex with respect to the Swiss legal aspects of the listing. The Homburger team comprised partner Frank Gerhard and associate Guy Deillon (both Corporate | M&A and Capital Markets).